UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts
Authors
Keywords
Medulloblastoma, PDX, UAB30, Retinoic acid
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-08-21
DOI
10.1007/s11060-018-2950-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The whole-genome landscape of medulloblastoma subtypes
- (2017) Paul A. Northcott et al. NATURE
- Preclinical Evaluation of UAB30 in Pediatric Renal and Hepatic Malignancies
- (2016) A. M. Waters et al. MOLECULAR CANCER THERAPEUTICS
- Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis
- (2016) Lizhi Wu et al. PLoS One
- Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids
- (2016) Barbara Bassani et al. PLoS One
- Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma
- (2015) A. M. Waters et al. MOLECULAR CANCER THERAPEUTICS
- Pediatric medulloblastoma xenografts including molecular subgroup 3 and CD133+ and CD15+ cells are sensitive to killing by oncolytic herpes simplex viruses
- (2015) Gregory K. Friedman et al. NEURO-ONCOLOGY
- PBX1 Is a Favorable Prognostic Biomarker as It Modulates 13-cis Retinoic Acid-Mediated Differentiation in Neuroblastoma
- (2014) N. Shah et al. CLINICAL CANCER RESEARCH
- Targeting Placental Growth Factor/Neuropilin 1 Pathway Inhibits Growth and Spread of Medulloblastoma
- (2013) Matija Snuderl et al. CELL
- Changes in Gene Expression Profiling of Apoptotic Genes in Neuroblastoma Cell Lines upon Retinoic Acid Treatment
- (2013) Jon Celay et al. PLoS One
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
- (2012) Marcel Kool et al. ACTA NEUROPATHOLOGICA
- PI3K/AKT and ERK regulate retinoic acid-induced neuroblastoma cellular differentiation
- (2012) Jingbo Qiao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Three Down and One To Go: Modeling Medulloblastoma Subgroups
- (2012) Charles G. Eberhart CANCER CELL
- Tyrosine phosphatase inhibitors combined with retinoic acid can enhance differentiation of neuroblastoma cells and trigger ERK- and AKT-dependent, p53-independent senescence
- (2012) Owen Clark et al. CANCER LETTERS
- TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid
- (2012) Muhammad Imran et al. EUROPEAN JOURNAL OF CANCER
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma
- (2012) A. W. Studebaker et al. NEURO-ONCOLOGY
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Assessment of oral toxicity and safety of 9-cis-UAB30, a potential chemopreventive agent, in rat and dog studies
- (2011) Matthew Lindeblad et al. DRUG AND CHEMICAL TOXICOLOGY
- CRABP-II methylation: A critical determinant of retinoic acid resistance of medulloblastoma cells
- (2011) Yuan-Shan Fu et al. Molecular Oncology
- Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition
- (2011) M Ying et al. ONCOGENE
- A Pilot, First-in-Human, Pharmacokinetic Study of 9cUAB30 in Healthy Volunteers
- (2010) J. M. Kolesar et al. Cancer Prevention Research
- Retinoids regulate stem cell differentiation
- (2010) Lorraine J. Gudas et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
- (2010) Yoon-Jae Cho et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas
- (2010) Renyuan Bai et al. NEURO-ONCOLOGY
- Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings
- (2009) Lisa Diller et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of the B-Raf/Mek/Erk MAP kinase pathway as a target for all-trans retinoic acid during skin cancer promotion
- (2009) Satish B Cheepala et al. Molecular Cancer
- Tumor Environment Dictates Medulloblastoma Cancer Stem Cell Expression and Invasive Phenotype
- (2008) B. Annabi et al. MOLECULAR CANCER RESEARCH
- Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice
- (2007) Surajit Karmakar et al. CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More